Ralph Highnam, Volpara Health Technologies

Ralph is the Founder & CEO of Volpara Health Technologies which develops digital health solutions for personalized, high-quality breast cancer screening based on objective measurements of breast density, compression and radiation dose. Volpara is an ASX-listed company with a value of over $300 million. Ralph talks about the benefit of being listed and quickly being able to raise follow-on funding.

https://volparasolutions.com/
At the MORGO retreats we hear incredible stories from people building tech companies out into the world. The Morgo Podcast shares these stories with you.

Look for The MORGO Podcast on your favourite podcast app and subscribe

More from the Morgo Podcast Series

Morgo Partners

Supported by New Zealand Trade & Enterprise